Prot# VP-VEC-162-3502: A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants with Delayed Sleep-Wake Phase Disorder (DSWPD).VP-VEC-162-3502

Project: Research project

Project Details

StatusActive
Effective start/end date3/23/219/26/24

Funding

  • CTI Clinical Trial and Consulting Services (Prot# VP-VEC-162-3502 // Prot# VP-VEC-162-3502)
  • Vanda Pharmaceuticals Inc. (Prot# VP-VEC-162-3502 // Prot# VP-VEC-162-3502)